双特异性抗体治疗复发/难治性多发性骨髓瘤:更新与未来展望 Bispecific antibodies for the treatment of relapsed/refractory multiple myeloma: updates and future perspectives. PubMed 2024/04/10 发表Front OncolQ2 · IF 3.4(JCR 2025) 靶点:BCMA靶点:GPRC5D靶点:FcRH5技术:NK 细胞技术:双特异性抗体多发性骨髓瘤